![A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation? - International Journal of Infectious Diseases A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation? - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5c228ecf-75e1-4eb2-b596-e3ca1a874c5a/gr1.jpg)
A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation? - International Journal of Infectious Diseases
![Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action - ScienceDirect Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879625711001647-gr1.jpg)
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action - ScienceDirect
![No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients - Journal of Hepatology No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7a47f808-9669-40ae-9a5a-598565fd1ae6/ga1_lrg.jpg)
No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients - Journal of Hepatology
![Sofosbuvir: Arrival of a paradigm shift in the management of hepatitis C in India Singh K, Kamat S K, Shukla A - J Med Soc Sofosbuvir: Arrival of a paradigm shift in the management of hepatitis C in India Singh K, Kamat S K, Shukla A - J Med Soc](https://www.jmedsoc.org/articles/2017/31/2/images/JMedSoc_2017_31_2_77_204827_f2.jpg)
Sofosbuvir: Arrival of a paradigm shift in the management of hepatitis C in India Singh K, Kamat S K, Shukla A - J Med Soc
![Ledipasvir/sofosbuvir Hepatitis C virus Mechanism of action Ribavirin, drug, text, dasabuvir, nucleoside Analogue png | PNGWing Ledipasvir/sofosbuvir Hepatitis C virus Mechanism of action Ribavirin, drug, text, dasabuvir, nucleoside Analogue png | PNGWing](https://w7.pngwing.com/pngs/965/848/png-transparent-ledipasvir-sofosbuvir-hepatitis-c-virus-mechanism-of-action-ribavirin-drug-miscellaneous-text-dasabuvir-thumbnail.png)
Ledipasvir/sofosbuvir Hepatitis C virus Mechanism of action Ribavirin, drug, text, dasabuvir, nucleoside Analogue png | PNGWing
![Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model | Scientific Reports Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-22620-2/MediaObjects/41598_2018_22620_Fig1_HTML.jpg)
Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model | Scientific Reports
![Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-73641-9/MediaObjects/41598_2020_73641_Fig1_HTML.png)
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
![Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review | Pharmacology Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review | Pharmacology](https://www.frontiersin.org/files/Articles/840639/fphar-13-840639-HTML-r1/image_m/fphar-13-840639-g001.jpg)
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review | Pharmacology
![Viruses | Free Full-Text | Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations | HTML Viruses | Free Full-Text | Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations | HTML](https://www.mdpi.com/viruses/viruses-08-00283/article_deploy/html/images/viruses-08-00283-g002.png)